RGS-PX1 (also known as sorting nexin 13) is a member of both the regulator of G protein signaling (RGS) and sorting nexin (SNX) protein families. Biochemical and cell culture studies have shown that RGS-PX1͞SNX13 attenuates G␣s-mediated signaling through its RGS domain and regulates endocytic trafficking and degradation of the epidermal growth factor receptor. To understand the functions of RGS-PX1͞SNX13 in vivo, we generated mice carrying targeted mutations of Snx13 and found that systemic Snx13-null mice were embryonic lethal around midgestation. Snx13-null embryos had significant overall growth retardation and defects in neural tube closure, blood vessel formation, and the formation of the placental labyrinthine layer. Moreover, the Snx13-null visceral yolk sac endoderm cells showed dramatic changes in the organization of endocytic compartments, abundant autophagic vacuoles, and abnormal localization of several endocytic markers, including megalin, a receptor for nutrients and proteins; ARH, a coat protein that binds megalin; LAMP2; and LC3. These changes suggest that Snx13-null embryos are defective in nutrient uptake and transport, which may contribute to the other developmental abnormalities observed. Taken together, our findings demonstrate an essential role for RGS-PX1͞SNX13 in mouse development and provide previously undescribed insights into its cellular function in the regulation of endocytosis dynamics.
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megalin ͉ receptor endocytosis ͉ regulator of G protein signaling ͉ visceral yolk sac endoderm R eceptor-mediated endocytosis is the process by which plasma membrane components and extracellular materials such as nutrients, hormones, antigens, and other macromolecules are selectively internalized into cytoplasmic vesicles, delivered to early and late endosomes and degraded in lysosomes or recycled back to the plasma membrane through recycling endosomes (1) (2) (3) . Trafficking between these endocytic compartments is highly regulated and often involves critical sorting steps. Recently, a large family of sorting nexin (SNX) proteins characterized by the presence of Phox (PX) domains has been identified and implicated in the regulation of different steps of the endocytic pathway (4, 5) . For example, the founding member of the SNX family, SNX1, was identified as an interacting partner of the epidermal growth factor receptor, and overexpression of SNX1 was found to enhance lysosomal degradation of epidermal growth factor receptor (6) . More recently, knock-down of SNX1 expression by RNA interference was shown to perturb the steady state distribution of the cation-independent mannose-6-phosphate receptor (CI-MPR) from the trans-Golgi network to endosomes and to increase the degradation rate of CI-MPR, establishing a role for SNX1 in endosome-to-trans-Golgi network transport (7) .
RGS-PX1 (also known as SNX 13, the designation by the human gene nomenclature committee) was identified originally as a member of the regulator of G protein signaling (RGS) protein family through bioinformatics analysis (8) . RGS-PX1 contains a characteristic RGS domain that specifically binds to the stimulatory subunit of the heterotrimeric G protein G␣s but not other G␣ proteins (8, 9 ) and serves as a GTPase activating protein for G␣s (8) . In addition, RGS-PX1͞SNX13 also contains a PX domain that preferentially binds to phosphatidylinositol-3-phosphate which is enriched in early endosomes (8) . We showed previously that RGS-PX1͞SNX13 is localized in early endosomes, and overexpression of RGS-PX1͞SNX13 delays the degradation of epidermal growth factor receptor, probably at the steps of endosome sorting and lysosomal targeting (8) . More recently, we found that RGS-PX1 and G␣s form a complex with Hrs (hepatocyte growth factor-regulated tyrosine kinase substrate), a critical component of the endosomal sorting machinery that targets ubiquitinated membrane proteins for sequestration into multivesicular bodies and subsequent degradation in lysosomes (10) . These studies using cultured mammalian cells demonstrated that RGS-PX1 plays an important role in the regulation of endocytic trafficking.
To understand the functions of RGS-PX1͞SNX13 in vivo, we generated Snx13-deficient mice through homologous recombination in ES cells. We show that Snx13 Ϫ/Ϫ embryos are growth retarded and die around midgestation. Mutant embryos also show defects in neural tube closure, vasculogenesis and placental development. Electron microscopy and immunofluorescence analysis revealed unusual prominent tubular endosomal compartments, presence of autophagic vacuoles, and redistribution of endosomal markers in mutant visceral yolk sac (VYS) endoderm. These results indicate that RGS-PX1͞SNX13 plays important roles in embryo development and in the dynamics of endocytosis in VYS endoderm and provide insights into the role of RGS-PX1͞SNX13 in receptor recycling and endosomal-lysosomal trafficking.
Results
Targeted Disruption of the Mouse RGS-PX1͞Snx13 Gene. To explore the function of RGS-PX1͞SNX13 in vivo, we disrupted the mouse gene through homologous recombination in ES cells (Fig. 1A-E) . A gene-targeting construct was assembled to allow the excision of coding exon 3 and removal of the marker genes by Cre recombinase that is expected to generate a translational frameshift mutation and a premature translation product containing only the N-terminal 42 residues of RGS-PX1. After electroporation and selection, ES cells were analyzed for homologous recombination by PCR and Southern blotting (Fig. 1F) . ES cells containing the type I systemic deletion mutant were microinjected into C57BL͞6 blastocysts to generate chimeric mice, which were bred with C57BL͞6 mice to produce germ-line-transmitted Snx13 ϩ/Ϫ mice.
Snx13 ؊/؊ Embryos Die at Midgestation. Both Snx13 heterozygous male and female mice were fertile and did not show obvious phenotypic abnormalities by the age of 18 months. However, breeding of Snx13 heterozygous mice resulted in no homozygous mice at birth ( Table 1 ), indicating that mice lacking SNX13 died during embryogenesis. To determine the time of embryonic death, embryos from timed matings between heterozygous mice were analyzed at different stages of gestation, and the genotypes of embryos were determined by PCR (Fig. 1G ). Between embryonic day (E) 8.5 and E10.5, Snx13 Ϫ/Ϫ embryos were found at the proper Mendelian ratio (Table 1 ). After E11.5, the number of viable mutant embryos decreased significantly (Table 1) . No live homozygous mutant embryos were found after E14.5 (Table 1) . A significant number of resorbing embryos and empty deciduas were also found from E10.5 to E13.5. RT-PCR performed on RNA isolated from homozygous Snx13 Ϫ/Ϫ and wild-type embryos or VYS confirmed that the targeted exon 3 is not present in the mutant RNA (Fig. 1H ).
Growth Retardation, Neural Tube Closure Defects and Impaired Vasculogenesis in Snx13 ؊/؊ Embryos. Between E8.5 and E13.5, Snx13 Ϫ/Ϫ embryos were significantly smaller than their wild-type littermates ( Fig. 2A) . Other than their small size, the most striking abnormality was that the Snx13 Ϫ/Ϫ embryos frequently showed failure of neural tube closure. At E10.5-11.5, mutant embryos typically presented with everted, open cranial neural folds ( Fig. 2 A and C) . We also analyzed the vascularization in wild-type and Snx13 Ϫ/Ϫ embryos by staining embryos for CD31 (PECAM-1), an endothelial marker.
We found that the mutant mice (Fig. 2C) showed a distinctly abnormal cephalic vascularization, less arborized compared with their wild-type littermates (Fig. 2B ). The number of capillaries was particularly small in the anterior (Fig. 2C ) and posterior aspects of neural folds that had failed to close, and the general organization of the capillary network was quite irregular.
Placental Defects in Snx13 ؊/؊ Embryos. We also analyzed the placentas of Snx13-null embryos around midgestation. At E10.5 the placentas of the Snx13 Ϫ/Ϫ mice were grossly similar, and histologically there were no distinct differences from their wild-type littermates (data not shown). By E11.5-E13.5, the placentas of the mutant embryos (Fig. 2E Inset) were significantly smaller than those of their wild-type littermates (Fig. 2D Inset) . At E11.5, the n, number of embryos that were dead͞resorbing; N͞D, genotype could not be dertermined due to technical difficulties. giant cell and spongiotrophoblast layers appeared similar in the wild-type ( Fig. 2D ) and mutant ( Fig. 2E) placentas. There were distinct abnormalities in the labyrinthine layer in the mutant placentas (Fig. 2 F and G) . The Snx13 Ϫ/Ϫ trophoblast cells had large nuclei and abundant granular cytoplasm, which often was more eosinophilic than that of the wild-type littermates. The apparent failure of labyrinthine trophoblast differentiation was accompanied by reduced maternal vascular spaces in the labyrinthine layer. The fetal blood supply appeared similar in both genotypes, but the Snx13 Ϫ/Ϫ fetal labyrinthine vessels often appeared wider than the corresponding wild-type vessels (Fig. 2 F and G) , suggesting a defect in branching morphogenesis. No clear changes were detected in the maternal decidua of the placentas at any stage studied. Taken together, these findings indicate that Snx13 Ϫ/Ϫ embryos have defective development of the labyrinthine layer of the placenta.
Abnormal Endosomal Compartments and Presence of Autophagic
Vacuoles in Snx13 ؊/؊ Visceral Yolk Sac Endoderm. During midgestation, the VYS endoderm which is derived from the embryo is the major supplier of nutrients for the mouse conceptus (11, 12) . The VYS endoderm cells are highly specialized for endocytosis and lysosomal degradation. Nutrients, such as proteins and vitamins taken up by endocytosis via the receptors megalin and cubilin (13) , are processed in lysosomes and the resultant products are delivered to the embryo (14, 15) . The abnormalities we observed in the mutant embryos, such as growth retardation and neural tube closure defects, could be related to functional defects in the VYS endoderm. To determine whether any morphological changes could be detected in the VYS endoderm we analyzed this cell layer from midgestation litters by electron microscopy. As shown in Fig.  3A , at E10.5 the wild-type VYS endoderm cells characteristically show abundant large vacuolar structures and smaller electron-dense tubular elements in their apical cytoplasm which represent components of the endosome͞lysosomal system. In the Snx13 Ϫ/Ϫ mutant VYS endoderm cells (Fig. 3B) , the characteristic large apical vacuoles are smaller and less numerous, and the dense tubules are more abundant and more elaborate. The latter resemble the branching dense apical tubules found in the cells of the kidney proximal tubule that carry endosomal markers and have been identified as recycling endosomal tubules (16, 17) .
At E11.5, the Snx13 Ϫ/Ϫ VYS endoderm cells show numerous large autophagic vacuoles (Fig. 3D ) that contain membranous residues not found in the VYS endoderm cells of the wild-type littermates (Fig. 3C) . Autophagic vacuoles are readily recognizable by their content of membranous whorls and other structures (Fig. 3D ). Autophagy represents a pathway for degradation of intracellular organelles and often occurs under pathologic conditions in which cells are stressed or lack proper nutrients (e.g., essential amino acids) (18) . The presence of autophagic vacuoles in E11.5 mutant embryos suggested potential defects in nutrient uptake through receptor-mediated endocytosis and͞or lysosomal degradation.
Redistribution of Endocytic Markers in Snx13
؊/؊ Mice. To further delineate the changes in the endosomal system we stained VYS for endocytic markers, including megalin (one of the main endocytic receptors of this epithelium), ARH (marker for coated vesicles and endosomes) and LAMP2 (a lysosomal marker). Megalin continually internalizes multiple proteins, including vitamin carriers, delivers them to endocytic compartments and recycles to the cell surface (13, 19) . Megalin is found throughout the endocytic system but at steady state is most concentrated in clathrin coated pits at the apical plasma membrane in the proximal kidney tubule, another epithelium involved in bulk endocytosis (17, 20) . In semithin frozen sections of cells from E11.5 wild-type VYS endoderm cells, megalin is mainly seen immediately beneath the apical plasma membrane (Fig. 4C) where it codistributes with the coat proteins ARH (Fig.  4C ) and clathrin (data not shown). In Snx13 Ϫ/Ϫ littermates, both megalin ( Fig. 4G) and ARH (Fig. 4H) have a much broader distribution in the apical cytoplasm, suggesting redistribution of megalin and ARH which escorts megalin to and through the apical tubular endosomal system (21) . The distribution of LAMP2 in the wild-type VYS endoderm cells (Fig. 4D ) coincided with the distribution of large cytoplasmic vacuoles with contents of varying density seen by phase contrast (Fig. 4A ) and electron microscopy ( Fig. 3 A and C) . In the VYS of Snx13 Ϫ/Ϫ mice (Fig. 4I) , LAMP2 antibodies stained the apical cytoplasm between the nucleus and early endosomes, the region where the autophagic vacuoles are often seen by EM.
To check for the presence of autophagy we stained VYS for the autophagy marker, LC3. LC3 typically is located in the cytoplasm but becomes associated with small ''preautophagosomes'' that surround the large autophagic vacuoles on initiation of autophagy (22). Interestingly, Snx13 Ϫ/Ϫ VYS cells showed numerous vesicles positive for LC3 surrounding the large autophagic vacuoles (Fig.  4J) . LC3-positive vesicles were rarely seen in the corresponding wild-type cells (Fig. 4E) . From these findings we conclude that in the VYS endoderm of wild-type embryos, vacuolated lysosomes are abundant reflecting the high levels of protein uptake, whereas in VYS endoderm cells of the Snx13 Ϫ/Ϫ mice tubular endosomes are abundant, fewer lysosomes are seen, and autophagy is prominent.
Discussion
In this study we generated a mutant allele of mouse Snx13 by gene targeting and demonstrated that RGS-PX1͞SNX13 plays an essential role in mouse development. Disruption of the Snx13 gene led to embryonic lethality around midgestation. Morphological and histological analyses revealed that mutant embryos showed overall growth retardation and defects in neural tube closure and vasculogenesis at earlier stages. It is interesting to note that homozygous disruption of the Gnas gene which encodes G␣s, the GTPase regulated by RGS-PX1͞SNX13, also led to embryonic lethality around E10.5 (23) . However, detailed characterization of the embryonic defects in Gnas Ϫ/Ϫ mice has not been reported. In addition to defects in the embryos, homozygous Snx13 mutants show striking defects in extra-embryonic tissues including the VYS endoderm and chorioallantoic placenta. VYS endoderm is an extra-embryonic cell layer of embryonic origin that plays important roles in nutrient uptake and transport (12) . VYS endoderm cells have microvilli and contain a highly developed endocytic͞lysosomal system, which allows efficient absorption and transport of nutrients from maternal sources to the fetus and degradation of maternal proteins in lysosomes to generate amino acids for protein synthesis in the fetus before the placenta taking over this function (11, 12, 14, 15) . By electron microcopy and immunofluorescence we show that the endocytic͞lysosomal compartments in the mutant VYS endoderm are dramatically altered compared with those of the wild-type VYS cells.
We consider that the defect in VYS endoderm is one of the most significant defects in Snx13 mutants and may contribute, at least partially, to the other abnormalities observed. To begin with, growth retardation in the mutant embryos may be explained by the defects in nutrient uptake in VYS endoderm and maternal-fetal exchange. Second, defects in the uptake of small molecule nutrients such as vitamins in VYS endoderm may lead to neural tube closure defects in embryos (24, 25) . Megalin, an endocytic receptor for multiple ligands including the vitamin B12-transcobalamin complex (26) and the retinol-binding protein-vitamin A complex (27) , is localized at the apical surface of VYS endoderm during development (13) . Cubilin, another receptor for the transport of vitamin B12, can also be found in VYS endoderm (13) . Mice lacking megalin also showed defects in the forebrain (28) . Furthermore, deficiency in vitamin B12 or retinoic acid has been shown to cause defects in neural tube closure in mice (25, 29) . Finally, there is also a potential link between defects in the yolk sac and the chorioallan- In contrast, by phase-contrast microscopy of E11.5 Snx13 Ϫ/Ϫ embryos (F), there are multiple vacuoles that appear smaller in size that those in wild-type embryos, and some most likely represent the autophagic vacuoles with heterogeneous contents seen by EM (Fig. 3) . In a Snx13-null littermate, megalin (G) and ARH (H) are more broadly distributed in endosomal compartments in the apical cytoplasm; LAMP2 (I) is found in some large ring-like structures, as well as in the giant autophagic vacuoles; and LC3 (J) staining is greatly increased and widely distributed in punctate preautophagosomes located throughout the cytoplasm surrounding the autophagic vacuoles. Increased staining for LC3 is indicative of increased autophagy. VYS were fixed in 4% PFA, and semithin cryosections were prepared and stained as described in Materials and Methods. (Scale bar: 5 m.) toic placenta. Placental hypoplasia with defective trophoblast differentiation and blood vessel development in the labyrinthine layer may result from a functional failure in vesicular transport of nutrients in VYS endoderm which is the primary structure responsible for the maintenance of the developing embryo and the formation of the chorioallantoic placenta before the establishment of the functional placenta. In the future it will be interesting to further examine the contribution of the extra-embryonic defects to the embryonic lethality and other features observed in Snx13 mutants either by tetraploid aggregations or by breeding mice contains floxed alleles of Snx13 (Snx13 F/F ) with another group of mice that carry Cre recombinase under the control of an epiblastspecific promoter such as meox2 (30) .
The abnormal endocytic͞lysosomal compartmentalization in the VYS endoderm cells of Snx13-null mutants provides new insights into understanding the cellular function of RGS-PX1͞SNX13 as a regulator of endocytic trafficking. Early endosomes contain two distinct domains, vesicular and tubular, which have been thought to be involved in receptor degradation and recycling pathways, respectively (2, 3). Tubular domains which are enriched for recycling receptors usually pinch off from the spherical core and form carriers for delivery to the cell surface. The unusual amount of these tubular structures observed in Snx13-null VYS endoderm cells might indicate a defect in the recycling pathway from early endosomes back to the apical cell surface or in trafficking through recycling endosomes in the pericentriolar region. This model is consistent with the finding that megalin distribution at the apical cell surface is much broader in mutant than in the wild-type cells. Megalin, a member of the low-density lipoprotein receptor family (31) , dissociates from its ligands in early endosomes and normally returns to the plasma membrane via the recycling pathway (13, 21) , and ARH escorts megalin throughout the endocytic pathway (21) . The change in megalin and ARH localization in mutant cells indicates a shift in its distribution to the inside of the cell (presumably to recycling endosomes) and suggests defects in their recycling to the plasma membrane. The implication that RGS-PX1͞SNX13 is involved in receptor recycling adds a new dimension to the role of RGS-PX1͞SNX13 in receptor degradation previously demonstrated by using cultured cells and ectopic expression (10) . Another striking feature in the Snx13-null VYS endoderm is the appearance of autophagic vacuoles which most likely reflects a deficiency in the supply of nutrients from endocytic uptake and͞or lysosomal degradation in these cells, as autophagy represents a major cellular response to nutrient deprivation (18) . We speculate that the presence of autophagic vacuoles may be secondary to the defects in receptor endocytosis and endosomal-lysosomal trafficking.
RGS-PX1͞SNX13, together with RGS-PX2͞SNX14 and RGS-PX3͞SNX25, forms the subfamily G of mammalian RGS proteins (8) . What distinguishes this subfamily from the rest of Ͼ25 different RGS proteins is the presence of PX domain, which can also be found in SNX proteins that regulate endocytic trafficking (5). Consistent with this unique feature, RGS-PX1 is the only RGS protein characterized so far that shows defects related to endocytic trafficking when mutated in mice.
Among the 29 SNX protein family members identified in mammals (5), SNX1 and SNX2 are the only ones for which genetargeted mice have been reported (32) . Whereas neither Snx1 Ϫ/Ϫ or Snx2 Ϫ/Ϫ mice show any obvious phenotypes, Snx1 Ϫ/Ϫ ;Snx2 Ϫ/Ϫ mice die at mid-gestation, suggesting that SNX1 and SNX2 have redundant functions (32) . Similar to Snx13 Ϫ/Ϫ mice reported here, Snx1 Ϫ/Ϫ ;Snx2 Ϫ/Ϫ mice also showed growth retardation, neural tube closure defects and abnormal morphology in apical VYS endoderm (32) . However, there are distinct differences between the defects seen in the VYS endoderm. Unlike the tubular structures in Snx13 Ϫ/Ϫ cells, increased amounts of apical globular dense structures were found in Snx1 Ϫ/Ϫ ;Snx2 Ϫ/Ϫ VYS endoderm cells (32) . These structures were labeled by acidic Lysotracker but did not appear to represent either early endosomes or mature lysosomes as judged by lack of immunostaining with EEA1, LAMP1 or LAMP2 antibodies. Also, no autophagy was reported. Moreover, in contrast to Snx13 Ϫ/Ϫ VYS endoderm cells, the LAMP2 staining pattern in Snx1 Ϫ/Ϫ ;Snx2 Ϫ/Ϫ VYS endoderm cells was the same as in the wild type (32) . The fact that tubular structures were more abundant and lysosomes smaller in the Snx13 Ϫ/Ϫ than in wild-type mice suggests a defect in the sorting or trafficking in endosomes. This possibility is consistent with the previously characterized role of RGS-PX1͞ SNX13 in the lysosomal degradation pathway (8) . Thus, differences between the phenotype of VYS endoderm cells of Snx1 Ϫ/Ϫ ;Snx2
and Snx13 Ϫ/Ϫ mice very likely reflect the involvement of these proteins in different steps of endocytic trafficking. Whereas RGS-PX1͞SNX13 colocalizes with EEA1 and hepatocyte growth factorregulated tyrosine kinase substrate (10) , presumably on the clathrin-coated domains of early endosomes, SNX1 is localized on the tubular domains of endosomes, only partially overlaps with EEA1 staining, and plays a role in endosome-to-trans-Golgi network transport (7) .
Taken together, our characterization of Snx13 gene targeted mice has revealed essential roles for SNX13͞RNS-PX1 in mouse development and the regulation of endocytosis dynamics in VYS endoderm cells. Furthermore, these studies provide new insights into the cellular function of RGS-PX1͞SNX13 as a sorting nexin. In this study we focused on the role of RGS-PX1͞SNX13 in the organization of endocytic compartments in VYS endoderm cells. Whether RGS-PX1͞SNX13 plays a similar role in other cell types remains to be seen. Future experiments will be aimed at understanding the underlying molecular mechanisms involved by investigating the functions of RGS-PX1͞SNX13 in adult mice by using the conditional knockout approach.
Materials and Methods Construction of the Targeting Vector.
A mouse 129͞SvJ genomic library (Stratagene, La Jolla, CA) was screened by using a 5Ј region of human RGS-PX1͞SNX13 cDNA. Three independent clones expanding Ϸ20-kb region including coding exons 1 to 5 were isolated, subcloned into the pBluescript SKII vector and mapped for restriction enzyme sites. The targeting vector was constructed by using these genomic clones and the pflox vector which contains three loxP sites and a tk-neo selection cassette (33) . A 2.0 kb SphI fragment containing coding exon 3 of Snx13 was inserted into the BamHI site of pflox, which was flanked by two loxP sites, and adjacent Snx13 genomic sequences were added by subcloning a 3.8-kb SphI fragment into the XhoI site and a 1.8-kb SphI-EcoRV fragment into the SalI site of pflox, respectively.
Electroporation and Selection of ES Cells. The NotI-linearized Snx13 targeting construct was electroporated into R1 embryonic stem (ES) cells followed by G418 (Invitrogen, Carlsbad, CA) selection. Resistant clones were screened for homologous recombination by PCR with the upstream TK-specific primer and the downstream gene-specific primer. PCR positive clones were analyzed by Southern blotting with a 3Ј external gene-specific probe to hybridize with KpnI-digested genomic DNA and a 5Ј probe with BamHI-digested genomic DNA. The presence of three loxP sites was confirmed by using a loxP -specific probe. Representative ES cell clones containing a targeted allele were electroporated with a Cre expressing vector pCre-Hygro. Following selection with gancyclovir, subclones were isolated and analyzed by Southern blotting to identify Cremediated type I (deletion of both exon 2 and tk-neo, Snx13 ⌬ allele) and type II (deletion of tk-neo only, Snx13 F ) mutants.
Generation of SNX13 Germ-Line Knockout Mice. Type I ES clones were microinjected into C57BL͞6 blastocysts at the Moores Cancer Center transgenic mouse core facility at the University of California at San Diego. Male chimeric mice were mated with C57BL͞6 females, and germ-line transmitted mice were bred with C57BL͞6 mice for up to five generations to produce heterozygous mice. The
